MBRX
Moleculin Biotech Inc
NASDAQ: MBRX · HEALTHCARE · BIOTECHNOLOGY
$2.48
-0.40% today
Updated 2026-05-06
Market cap
$13.39M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-28.42
Dividend yield
—
52W range
$2 – $29
Volume
0.1M
Moleculin Biotech Inc (MBRX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |